Show simple item record

dc.rights.licenseopenen_US
dc.contributor.authorDROZ-PERROTEAU, C.
dc.contributor.authorBLIN, Patrick
dc.contributor.authorDUREAU-POURNIN, C.
dc.contributor.authorTHOMAS, D.
dc.contributor.authorDANCHIN, N.
dc.contributor.authorTRICOIRE, J.
dc.contributor.authorPAILLARD, F.
dc.contributor.authorHERCBERG, S.
dc.contributor.authorGUIZE, L.
dc.contributor.authorGUIARD, E.
dc.contributor.authorMAIZI, H.
dc.contributor.authorBERNARD, M. A.
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorBENICHOU, Jacques
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorMOORE, Nicholas
dc.date.accessioned2020-06-05T13:42:29Z
dc.date.available2020-06-05T13:42:29Z
dc.date.issued2019-09
dc.identifier.issn1958-5578 (Electronic) 0040-5957 (Linking)en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/7790
dc.description.abstractEnBACKGROUND: Studies of survival after myocardial infarction (MI) are often based on intention to treat analyses of controlled trials. OBJECTIVES: Describe long-term survival after MI in France. METHODS: Six-year cohort study of patients recruited within 3 months after MI. Primary outcome was all-cause death. Vital status was verified in the national death registry. Analysis used Cox models with time-dependent variables and propensity scores. RESULTS: Five thousand five hundred and twenty-seven (5527) subjects were included, 62.1+/-13 years old, 77.6% male, 9.6% smokers, 16.7% diabetic, 13.3% with previous MI. Up to 99% of patients were initially prescribed secondary prevention drugs (aspirin and/or other antiplatelet agents, beta-blockers, statins or other lipid-lowering agents, angiotensin converting enzyme inhibitors or angiotensin receptor blockers); 73% had all four classes. Overall 6-year mortality was 13.1% [95% confidence interval 12.3 to 14.0%], 2.34 per hundred patient-years (% PY); 49% returned all or all but one of the possible questionnaires (compliant [C]), 50.8% did not (non-compliant [NC]). The main predictors for death were non-compliance with study protocol (death rates NC 2.98% PY, C 1.69%PY, hazard ratio (HR) 3.13 [2.63-3.57]); increasing age at inclusion (HR up to 15.7 [10.7-23.2] for age >/=80); diabetes (1.39 [1.17-1.65]); smoking at inclusion (1.76 [1.27-2.44]), previous MI (1.46 [1.22-1.75]). Beta-blockers (0.79 [0.64-0.96]), statins (0.68 [0.51-0.90]), and enrolment in physical rehabilitation programs (0.74 [0.62-0.89]) were associated with a lower death rate. CONCLUSION: Association of mortality with non-compliance to study protocol probably indicates general non-compliance with prevention. Analyses of treatment effects were hindered by paucity of events and of unexposed patients.
dc.language.isoENen_US
dc.subject.enPharmacoEpi-Drugs
dc.title.enSix-year survival study after myocardial infarction: The EOLE prospective cohort study. Long-term survival after MI
dc.typeArticle de revueen_US
dc.identifier.doi10.1016/j.therap.2019.02.001en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed30878144en_US
bordeaux.journalThérapieen_US
bordeaux.page459-468en_US
bordeaux.volume74en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - U1219en_US
bordeaux.issue4en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-03211507
hal.version1
hal.date.transferred2021-04-28T15:35:40Z
hal.exporttrue
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Th%C3%A9rapie&rft.date=2019-09&rft.volume=74&rft.issue=4&rft.spage=459-468&rft.epage=459-468&rft.eissn=1958-5578%20(Electronic)%200040-5957%20(Linking)&rft.issn=1958-5578%20(Electronic)%200040-5957%20(Linking)&rft.au=DROZ-PERROTEAU,%20C.&BLIN,%20Patrick&DUREAU-POURNIN,%20C.&THOMAS,%20D.&DANCHIN,%20N.&rft.genre=article


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record